July. 19, 2022

Ribbon Biolabs’ first patent issued by the US Patent Office.

We are very proud to announce the issuance of our first U.S. patent covering our novel method for synthesizing double stranded DNA using a diverse library of oligonucleotides.


Meet us at SynBioBeta 2023

May 17, 2023 - VIENNA, AUSTRIA: SynBioBeta - the largest synthetic biology industry conference - is back in 2023 and Ribbon Biolabs is very excited to be part of it. For the first time, Ribbon...

Ribbon Biolabs is Falling Walls Winner 2022

We are thrilled to be shortlisted as one of 25 winners of the Falling Walls Venture 2022!  Falling Walls Venture is a global platform for the most promising science start-ups who have successfully...